HBMN — HBM Healthcare Investments AG Share News
0.000.00%
- CH₣1.48bn
- CH₣1.63bn
- CH₣297.06m
Brief: HBM Portfolio Company Ambrx Biopharma Raises $126 Million In IPO
Swiss stocks - Factors to watch on June 18
Brief: HBM Healthcare Investments To Issue Bond
Swiss stocks - Factors to watch on June 11
Brief: HBM Says Valo Health And Khosla Ventures Acquisition To Combine And Create Publicly Traded Company
Swiss stocks - Factors to watch on June 10
Brief: HBM Says Swixx Biopharma Announces EUR 45 Mln Capital Increase
Additional Investment in Portfolio Company
New Investment in Numab Therapeutics
BMO Mgd Ptfo Tst. - Portfolio Update
Brief: HBM Proposes Dr Elaine V. Jones To Be Elected To Board Of Directors
Brief: HBM Healthcare FY Profit At CHF 756 Million
Brief: HBM Healthcare Investments FY Profit Climbs To CHF 750 Million
Brief: HBM IPOs Of Instil Bio And Connect Biopharma Ups Net Asset Value By 1.5%
Swiss stocks - Factors to watch on March 22
Swiss stocks - Factors to watch on March 15
Brief: HBM Portfolio Company Longboard Pharmaceuticals Raises $80 Million In IPO
Swiss stocks - Factors to watch on February 2
Brief: Horizon Therapeutics To Acquire Viela Bio For USD 3.05 Bln